AG0010SF

132539-06-1 | 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene

Chemical structure of 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene, CAS 132539-06-1
AG0010SF
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 132539-06-1
Catalog Number AG0010SF(AGN-PC-0PJR5G)
Chemical Name 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene
IUPAC Name 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
InChI InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
InChI Key KVWDHTXUZHCGIO-UHFFFAOYSA-N
MDL Number MFCD00866702
Molecular Formula C17H20N4S
Molecular Weight 312.4325
SMILES CC1=CC2=C(NC3=C(N=C2N2CCN(CC2)C)C=CC=C3)S1
UNII N7U69T4SZR
Synonyms
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine, LY 170052, LY 170053, LY-170052, LY170052, olanzapine, olanzapine pamoate, Zolafren, Zyprexa, olanzapine, 132539-06-1, Zyprexa, Zyprexa Zydis, Olansek, Zalasta, Zyprexa Intramuscular, Zyprexa Velotab, olanzapinum, LY-170053, Zolafren, Zypadhera, Lanzac, 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine, LY 170053, 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine, Olzapin, Oferta, UNII-N7U69T4SZR, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine, 10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, CHEMBL715, N7U69T4SZR, 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine, CHEBI:7735, C17H20N4S, KVWDHTXUZHCGIO-UHFFFAOYSA-N, MFCD00866702, olanzapina, NCGC00096077-03, LY170053, DSSTox_CID_3388, DSSTox_RID_77010, DSSTox_GSID_23388, Midax, Zydis, Olanzapine [USAN:INN], Olanzapine Mylan, 2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine, Olanzapine Teva, 10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene, Olanzapine (OLA), SMR000466345, Olanzapine Neopharma, CAS-132539-06-1, SR-01000759343, Olanzapin, Olanzapine (JAN/USAN/INN), LY-170052, ALKS-7921, HSDB 8155, Olanzapine [USAN:USP:INN:BAN], Olanzapine(Zyprexa), Olanzapine (Zyprexa), KS-1090, AC1L1IHS, ACMC-209wx7, GTPL47, BIDD:PXR0138, SCHEMBL28763, US8802672, Olanzapine, KSC177A9B, MLS000759457, MLS001165781, MLS001195646, MLS001424057, BIDD:GT0332, SCHEMBL117695, SPECTRUM1505024, Jsp001969, DTXSID9023388, Olanzapine, >=98% (HPLC), BDBM35254, BDBM82479, CHEBI:94534, CTK0H7090, CTK6I2959, KS-00000XJV, HMS2051H05, HMS2089M04, HMS2093I04, HMS2233F24, HMS3374L02, HMS3393H05, HMS3657I15, HMS3714J03, ACT03231, ALBB-027265, BCP04917, EBD23216, NSC_4585, ZINC3873830, Tox21_111556, AC-665, ANW-46937, CO0033, s2493, STK634338, STL388024, ZINC52957434, 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine, AKOS000282888, AKOS005566122, Olanzapine 1.0 mg/ml in Acetonitrile, Tox21_111556_1, ACN-029909, AN-6960, BCP9001021, CCG-100922, CS-1114, DB00334, MCULE-1620364835, NC00172, NCGC00096077-01, NCGC00096077-04, NCGC00096077-05, NCGC00096077-06, NCGC00389791-02, BC206213, BR-57874, CJ-20712, CPD000466345, HY-14541, I960, SAM001246652, SC-16244, SBI-0206786.P001, AB0013948, AB1008596, AJ-112146, LS-152313, RT-003566, ST2417070, TL8000772, CAS_132539-06-1, FT-0612957, O0393, SW220248-1, A10667, C07322, D00454, J10363, S-4287, AB00639907-06, AB00639907-07, AB00639907_08, AB00639907_09, 539O061, A806453, L000455, L005958, I06-0784, J-006186, SR-01000759343-4, SR-01000759343-6, Z1868057799, Olanzapine, European Pharmacopoeia (EP) Reference Standard, Olanzapine, United States Pharmacopeia (USP) Reference Standard, Olanzapine, Pharmaceutical Secondary Standard; Certified Reference Material, (E)-2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine, 2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene, 2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine #, 2-methyl-4-(4-methylpiperazin-1-yl)-5H-benzo[b]thieno[2,3-e][1,4]diazepine, 5h-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard, Olanzapine-d8, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Lanzac; Zyprexa, 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0(3),?]tetradeca-1(14),3(7),5,8,10,12-hexaene, 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0(3),]tetradeca-1(14),3(7),5,8,10,12-hexaene, 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),2,5,7,11,13-hexaene, Olanzapine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Symbyax, Integrol, Olazax, Olanzapine pamoate, Olanzapine Teva, Olazax Disperzi, Mixture Name, Zyprexa Relprevv, Zyprexa (TN), olanzapine embonate, Olanzapine Glenmark, Zolafren (TN), Olzapin (TN), Rexapin (TN), Zalasta (TN), Zydis (TN), Lilly brand of olanzapine, Olanzapine Glenmark Europe, D0V4QS, Olanzapine pamoate monohydrate, Eli Lilly brand of olanzapine, CID4585, C17-H20-N4-S, CS-O-30992, LY170052, LY 170052, B2240, C076029, D000077152, 10H-tieno [2,3-b] [1,5 benzodiazepina], 2-metil-4-(4-metil-1-piperacinil)-, 2-methyl-4-(4-methyl-1-piperazinyl)-10 H-thieno[2,3-b ] [1,5]benzodiazepine, 57-88-5, Olanzapine, 99%, a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist - 1g 1g,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited